CRDF
Cardiff Oncology, Inc.
Company overview
- Market capitalization
- $93.35M
- Employees
- 30
- Latest publication
- 2026-09-29
About Cardiff Oncology, Inc.
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers in the United States. Its lead drug candidate is Onvansertib, an oral and selective polo-like kinase 1 inhibitor for treating RAS-mutated metastatic colorectal cancer. The company also focuses on the clinical program in indications, such as investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma, small cell lung cancer, metastatic triple negative breast cancer, and chronic myelomonocytic leukemia; CRDF-004, a Phase 2 open-label randomized multi-center clinical trial of onvansertib in combination with FOLFIRI and bevacizumab or FOLFOX and bevacizumab for the treatment of patients confirmed metastatic and unresectable colorectal cancer in patients with a KRAS or NRAS mutation; and TROV-054, a Phase 1b/2 single-arm clinical trial in KRAS-mutated metastatic colorectal cancer. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was founded in 1999 and is headquartered in San Diego, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 104,000USD | 41,000USD | 243,000USD | 120,000USD | 109,000USD | 151,000USD | 163,000USD | 205,000USD |
| Research Development | 5,915,000USD | 6,765,000USD | 5,075,000USD | 8,197,000USD | 10,477,000USD | 9,712,000USD | 9,493,000USD | 8,008,000USD |
| Selling General Administrative | 3,804,000USD | 6,126,000USD | 2,995,000USD | 3,897,000USD | 4,014,000USD | 3,011,000USD | 2,756,000USD | 3,130,000USD |
| Total Operating Expenses | 9,719,000USD | 12,891,000USD | 8,070,000USD | 12,094,000USD | 14,491,000USD | 12,723,000USD | 12,603,000USD | 11,036,000USD |
| Operating Income | -9,615,000USD | -12,850,000USD | -7,827,000USD | -11,974,000USD | -14,382,000USD | -12,572,000USD | -12,545,000USD | -10,933,000USD |
| Total Other Income Expense Net | 383,000USD | 505,000USD | 611,000USD | 716,000USD | 948,000USD | 785,000USD | 767,000USD | 922,000USD |
| Interest Income | 382,000USD | 506,000USD | 612,000USD | 716,000USD | 941,000USD | 787,000USD | 805,000USD | 926,000USD |
| Net Income | -9,232,000USD | -12,345,000USD | -7,216,000USD | -11,258,000USD | -13,434,000USD | -11,787,000USD | -11,778,000USD | -10,011,000USD |
| Net Income Applicable To Common Shares | -9,238,000USD | — | — | — | — | — | — | — |
| Cost Of Revenue | — | 221,000USD | 223,000USD | — | — | 96,000USD | 105,000USD | 102,000USD |
| Gross Profit | — | 41,000USD | 243,000USD | 120,000USD | 109,000USD | 151,000USD | 58,000USD | 103,000USD |
| Net Interest Income | — | 506,000USD | 612,000USD | 716,000USD | 941,000USD | 787,000USD | 805,000USD | 926,000USD |
| Income Before Tax | — | -12,345,000USD | -7,216,000USD | -11,258,000USD | -13,434,000USD | -11,787,000USD | -11,778,000USD | -10,011,000USD |
| Net Income From Continuing Ops | — | -12,345,000USD | -7,216,000USD | -11,258,000USD | -13,434,000USD | -11,787,000USD | -11,778,000USD | -10,011,000USD |
| Ebit | — | -12,345,000USD | -7,216,000USD | -11,258,000USD | -13,434,000USD | -11,787,000USD | -11,778,000USD | -10,011,000USD |
| Ebitda | — | -12,124,000USD | -6,993,000USD | -10,764,000USD | -13,206,000USD | -11,691,000USD | -11,673,000USD | -9,909,000USD |
| Depreciation And Amortization | — | 221,000USD | 223,000USD | 494,000USD | 228,000USD | 96,000USD | 105,000USD | 102,000USD |
| Reconciled Depreciation | — | 221,000USD | 223,000USD | 494,000USD | 228,000USD | 96,000USD | 105,000USD | 102,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | 757,000USD | 459,000USD | 102,000USD |
| Income Tax Expense | — | — | — | — | — | — | — | 58,724USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20142014-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 593,000USD | 683,000USD | 488,000USD | 359,000USD | 366,000USD | 244,632USD | 378,000USD | 280,000USD |
| Cost Of Revenue | 904,000USD | 404,000USD | 398,000USD | 500,000USD | 11,235,000USD | 11,162,236USD | 597,000USD | 15,000USD |
| Gross Profit | 593,000USD | 683,000USD | 488,000USD | 359,000USD | 366,000USD | 244,632USD | -219,000USD | 265,000USD |
| Research Development | 35,329,000USD | 36,852,000USD | 32,857,000USD | 17,376,000USD | 11,235,000USD | 11,162,236USD | 8,164,000USD | 6,665,000USD |
| Selling General Administrative | 14,224,000USD | 12,482,000USD | 13,043,000USD | 11,838,000USD | 8,217,000USD | 5,760,890USD | 8,005,583USD | 5,810,000USD |
| Total Operating Expenses | 49,553,000USD | 49,334,000USD | 45,900,000USD | 29,214,000USD | 19,452,000USD | 16,923,126USD | 16,170,000USD | 15,210,000USD |
| Operating Income | -48,960,000USD | -48,651,000USD | -45,412,000USD | -28,855,000USD | -19,086,000USD | -16,678,494USD | -17,053,000USD | -14,945,000USD |
| Interest Income | 3,104,000USD | 3,259,000USD | 3,801,000USD | 264,000USD | 89,809USD | 234,169USD | 219,430USD | — |
| Net Interest Income | 3,104,000USD | 3,259,000USD | 3,801,000USD | 264,000USD | 88,290USD | 234,169USD | 194,021USD | — |
| Income Before Tax | -45,851,000USD | -45,431,000USD | -41,441,000USD | -28,291,000USD | -19,307,000USD | -16,414,159USD | -16,461,000USD | -14,325,000USD |
| Net Income | -45,851,000USD | -45,431,000USD | -41,441,000USD | -28,291,000USD | -19,307,000USD | -16,414,159USD | -16,461,000USD | -14,325,000USD |
| Net Income From Continuing Ops | -45,851,000USD | -45,431,000USD | -40,801,000USD | -28,291,000USD | -19,278,428USD | -16,416,137USD | -16,224,345USD | -14,325,484USD |
| Ebit | -45,851,000USD | -45,431,000USD | -41,441,000USD | -28,291,000USD | -19,305,000USD | -16,414,159USD | -16,435,765USD | -14,945,159USD |
| Ebitda | -44,947,000USD | -45,027,000USD | -41,043,000USD | -27,840,000USD | -18,839,000USD | -15,919,927USD | -15,699,677USD | -14,710,346USD |
| Depreciation And Amortization | 904,000USD | 404,000USD | 398,000USD | 451,000USD | 466,000USD | 494,232USD | 736,088USD | 234,813USD |
| Reconciled Depreciation | 904,000USD | 404,000USD | 381,000USD | 451,000USD | 466,009USD | 494,232USD | 859,487USD | — |
| Total Other Income Expense Net | 3,109,000USD | 3,220,000USD | 3,971,000USD | 564,000USD | -221,000USD | 264,335USD | -72,453USD | 619,675USD |
| Income Tax Expense | — | -24,000USD | 230,105USD | -549,000USD | -26,725USD | -262,000USD | 617,643USD | 608,187USD |
| Selling And Marketing Expenses | — | — | 398,000USD | — | — | — | 417USD | 2,735,000USD |
| Interest Expense | — | — | — | 264,000USD | 2,000USD | 234,169USD | 25,409USD | 843,000USD |
| Non Operating Income Net Other | — | — | — | 564,000USD | -191,035USD | 262,357USD | 854,476USD | 1,462,934USD |
| Net Income Applicable To Common Shares | — | — | — | -28,315,000USD | -22,597,396USD | -16,706,668USD | -19,254,951USD | -14,348,499USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 37,329,000USD | 49,172,000USD | 61,884,000USD | 63,780,000USD | 75,739,000USD | 84,807,000USD | 97,190,000USD | 62,896,000USD |
| Cash And Equivalents | 9,197,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 34,520,000USD | 46,056,000USD | 58,304,000USD | 60,591,000USD | 70,957,000USD | 79,887,000USD | 91,746,000USD | 57,667,000USD |
| Short Term Investments | 25,323,000USD | 37,512,000USD | 40,834,000USD | 50,456,000USD | 60,173,000USD | 55,792,000USD | 40,276,000USD | 44,629,000USD |
| Total Current Assets | 35,592,000USD | 47,342,000USD | 60,128,000USD | 61,801,000USD | 73,696,000USD | 82,711,000USD | 95,054,000USD | 59,332,000USD |
| Other Non Current Assets | 927,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 10,797,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 10,797,000USD | 14,463,000USD | 16,394,000USD | 14,706,000USD | 16,669,000USD | 13,291,000USD | 13,428,000USD | 12,525,000USD |
| Other Current Liabilities | 6,354,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 26,532,000USD | 34,709,000USD | 45,388,000USD | 48,790,000USD | 58,606,000USD | 70,876,000USD | 82,949,000USD | 49,392,000USD |
| Total Equity Including Noncontrolling Interest | 26,532,000USD | — | — | — | — | — | — | — |
| Net Receivables | 189,000USD | 191,000USD | 182,000USD | 254,000USD | 526,000USD | 405,000USD | 773,000USD | 618,000USD |
| Property Plant Equipment Net | 810,000USD | 986,000USD | 1,207,000USD | 1,430,000USD | 1,642,000USD | 1,839,000USD | 2,067,000USD | 2,297,000USD |
| Accounts Payable | 3,986,000USD | 5,480,000USD | 8,087,000USD | 2,441,000USD | 6,010,000USD | 3,629,000USD | 4,821,000USD | 4,643,000USD |
| Short Term Debt | 457,000USD | 646,000USD | 730,000USD | 726,000USD | 721,000USD | 716,000USD | 710,000USD | 707,000USD |
| Common Stock | 7,000USD | 7,000USD | 7,000USD | 7,000USD | 7,000USD | 7,000USD | 7,000USD | 5,000USD |
| Retained Earnings | -451,607,000USD | -442,375,000USD | -430,030,000USD | -422,814,000USD | -411,556,000USD | -397,613,000USD | -384,179,000USD | -372,392,000USD |
| Accumulated Other Comprehensive Income | -62,000USD | -49,000USD | 50,000USD | 50,000USD | 17,000USD | 27,000USD | 34,000USD | 82,000USD |
| Other Current Assets | — | 1,095,000USD | 1,642,000USD | 956,000USD | 2,213,000USD | 2,419,000USD | 2,535,000USD | 1,047,000USD |
| Total Liab | — | 14,463,000USD | 16,496,000USD | 14,990,000USD | 17,133,000USD | 13,931,000USD | 14,241,000USD | 13,504,000USD |
| Other Current Liab | — | 8,337,000USD | 7,577,000USD | 11,539,000USD | 9,938,000USD | 8,946,000USD | 7,897,000USD | 7,175,000USD |
| Capital Stock | — | 7,000USD | 7,000USD | 7,000USD | 7,000USD | 7,000USD | 7,000USD | 5,000USD |
| Cash | — | 8,544,000USD | 17,470,000USD | 10,135,000USD | 10,784,000USD | 24,095,000USD | 51,470,000USD | 13,038,000USD |
| Net Debt | — | -7,898,000USD | -16,638,000USD | -9,125,000USD | -9,599,000USD | -22,739,000USD | -49,947,000USD | -11,352,000USD |
| Short Long Term Debt Total | — | 646,000USD | 832,000USD | 1,010,000USD | 1,185,000USD | 1,356,000USD | 1,523,000USD | 1,686,000USD |
| Property Plant Equipment Gross | — | 5,540,000USD | 5,674,000USD | 5,832,000USD | 5,966,000USD | 6,069,000USD | 6,204,000USD | 6,353,000USD |
| Common Stock Shares Outstanding | — | 68,350,000shares | 66,841,000shares | 66,879,000shares | 66,526,000shares | 47,650,000shares | 47,650,000shares | 46,865,000shares |
| Non Current Assets Total | — | 1,830,000USD | 1,756,000USD | 1,979,000USD | 2,043,000USD | 2,096,000USD | 2,136,000USD | 3,564,000USD |
| Non Current Liabilities Total | — | 0USD | 102,000USD | 284,000USD | 464,000USD | 640,000USD | 813,000USD | 979,000USD |
| Non Currrent Assets Other | — | 844,000USD | 549,000USD | 549,000USD | 401,000USD | 257,000USD | 69,000USD | 1,267,000USD |
| Net Working Capital | — | 32,879,000USD | 43,734,000USD | 47,095,000USD | 57,027,000USD | 69,420,000USD | 81,626,000USD | 46,807,000USD |
| Unclassified Equity | — | 477,119,000USD | 475,354,000USD | 471,540,000USD | 470,131,000USD | 468,448,000USD | 467,080,000USD | 421,692,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 61,884,000USD | 97,190,000USD | 81,637,000USD | 116,191,000USD | 149,544,000USD | 134,727,000USD | 13,086,546USD | 14,172,000USD |
| Other Current Assets | 1,642,000USD | 2,535,000USD | 2,301,000USD | 5,246,000USD | 4,771,000USD | 2,055,000USD | 954,957USD | 1,144,377USD |
| Total Liab | 16,496,000USD | 14,241,000USD | 11,898,000USD | 9,848,000USD | 9,127,000USD | 6,569,000USD | 5,775,202USD | 4,088,000USD |
| Total Stockholder Equity | 45,388,000USD | 82,949,000USD | 69,739,000USD | 106,343,000USD | 140,417,000USD | 128,158,000USD | 7,311,344USD | 10,084,000USD |
| Other Current Liab | 7,577,000USD | 7,897,000USD | 7,783,000USD | 5,177,000USD | 4,569,000USD | 3,893,000USD | 3,260,061USD | 2,258,478USD |
| Common Stock | 7,000USD | 7,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 8,312USD | 7,742USD |
| Capital Stock | 7,000USD | 7,000USD | 4,000USD | 4,000USD | 5,000USD | 4,394USD | 8,372USD | 7,802USD |
| Retained Earnings | -430,030,000USD | -384,179,000USD | -339,541,000USD | -298,100,000USD | -259,810,000USD | -231,495,000USD | -208,897,883USD | -192,191,215USD |
| Cash | 17,470,000USD | 51,470,000USD | 21,655,000USD | 16,347,000USD | 11,943,000USD | 130,981,000USD | 10,195,292USD | 11,453,000USD |
| Cash And Short Term Investments | 58,304,000USD | 91,746,000USD | 74,823,000USD | 105,267,000USD | 140,821,000USD | 130,981,000USD | 10,195,292USD | 11,453,000USD |
| Total Current Assets | 60,128,000USD | 95,054,000USD | 77,412,000USD | 111,284,000USD | 146,127,000USD | 133,356,000USD | 11,353,729USD | 12,765,000USD |
| Total Current Liabilities | 16,394,000USD | 13,428,000USD | 10,440,000USD | 7,808,000USD | 6,559,000USD | 6,119,000USD | 4,781,744USD | 2,965,000USD |
| Net Debt | -16,638,000USD | -49,947,000USD | -19,506,000USD | -13,632,000USD | -8,824,000USD | -130,112,000USD | -8,468,950USD | -11,453,000USD |
| Short Term Debt | 730,000USD | 710,000USD | 691,000USD | 675,000USD | 551,000USD | 860,000USD | 865,379USD | — |
| Short Long Term Debt Total | 832,000USD | 1,523,000USD | 2,149,000USD | 2,715,000USD | 3,119,000USD | 869,000USD | 1,726,342USD | — |
| Short Term Investments | 40,834,000USD | 40,276,000USD | 53,168,000USD | 88,920,000USD | 128,878,000USD | 0USD | — | — |
| Net Receivables | 182,000USD | 773,000USD | 288,000USD | 771,000USD | 535,000USD | 320,000USD | 203,480USD | 167,755USD |
| Accounts Payable | 8,087,000USD | 4,821,000USD | 1,966,000USD | 1,956,000USD | 1,439,000USD | 1,366,000USD | 656,304USD | 664,840USD |
| Property Plant Equipment Net | 1,207,000USD | 2,067,000USD | 2,946,000USD | 3,520,000USD | 3,178,000USD | 967,000USD | 1,575,241USD | 1,304,000USD |
| Property Plant Equipment Gross | 5,674,000USD | 6,204,000USD | 6,698,000USD | 3,520,000USD | 3,178,000USD | 966,695USD | 1,575,241USD | 1,304,433USD |
| Accumulated Other Comprehensive Income | 50,000USD | 34,000USD | -67,000USD | -395,000USD | -142,000USD | -2,170,999USD | -971,672USD | -2,110,061USD |
| Common Stock Shares Outstanding | 66,841,000shares | 47,650,000shares | 44,677,000shares | 43,600,000shares | 39,030,000shares | 20,875,000shares | 5,973,906shares | 2,330,180shares |
| Non Current Assets Total | 1,756,000USD | 2,136,000USD | 4,225,000USD | 4,907,000USD | 3,417,000USD | 1,371,000USD | 1,732,817USD | 1,407,000USD |
| Non Current Liabilities Total | 102,000USD | 813,000USD | 1,458,000USD | 2,040,000USD | 2,568,000USD | 450,000USD | 993,458USD | 1,123,000USD |
| Non Currrent Assets Other | 549,000USD | 69,000USD | 1,279,000USD | 1,387,000USD | 239,000USD | 404,000USD | 157,576USD | 103,000USD |
| Net Working Capital | 43,734,000USD | 81,626,000USD | 66,972,000USD | 103,476,000USD | 139,568,000USD | 127,237,483USD | 6,571,985USD | 9,799,947USD |
| Unclassified Equity | 475,354,000USD | 467,080,000USD | 409,339,000USD | 404,830,000USD | 400,360,000USD | 361,815,605USD | 217,164,215USD | 204,369,732USD |
| Other Assets | — | — | 1USD | 1,387,000USD | 239,000USD | 404,232USD | 157,576USD | 102,798USD |
| Unclassified Non Current Liabilities | — | — | 1,458,000USD | — | — | — | — | -1,164,972USD |
| Non Current Liabilities Other | — | — | — | 2,040,000USD | 2,568,000USD | 165,557USD | 989,331USD | — |
| Net Tangible Assets | — | — | — | 106,343,000USD | 140,416,000USD | 128,157,166USD | 7,311,284USD | 10,084,132USD |
| Unclassified Non Current Assets | — | — | — | -1,387,000USD | — | — | — | — |
| Current Deferred Revenue | — | — | — | — | 4,527,000USD | 3,850,763USD | — | — |
| Unclassified Current Liabilities | — | — | — | — | -4,527,000USD | -3,850,763USD | — | — |
| Deferred Long Term Liab | — | — | — | — | — | 284,971USD | 4,127USD | 1,122,986USD |
| Other Liab | — | — | — | — | — | 441,237USD | 132,495USD | 1,164,986USD |
| Inventory | — | — | — | — | — | — | 1USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -12,345,000USD | -7,216,000USD | -11,258,000USD | -13,943,000USD | -13,434,000USD | -11,787,000USD | -11,855,000USD | -11,778,000USD |
| Depreciation | 221,000USD | 223,000USD | 494,000USD | 229,000USD | 228,000USD | 96,000USD | 101,000USD | 105,000USD |
| Stock Based Compensation | 1,660,000USD | 1,261,000USD | 1,384,000USD | 1,683,000USD | 1,365,000USD | 1,204,000USD | 1,253,000USD | 1,179,000USD |
| Other Non Cash Items | -93,000USD | -158,000USD | -252,000USD | -301,000USD | -137,000USD | -158,000USD | -157,000USD | -127,000USD |
| Change To Account Receivables | -9,000USD | 72,000USD | 272,000USD | -121,000USD | 368,000USD | -154,000USD | -167,000USD | -58,000USD |
| Change In Working Capital | -1,731,000USD | -77,000USD | -1,202,000USD | 4,003,999USD | -816,000USD | 378,000USD | 202,000USD | 1,391,000USD |
| Total Cash From Operating Activities | -12,288,000USD | -5,967,000USD | -10,834,000USD | -8,327,999USD | -12,794,000USD | -10,267,000USD | -10,456,000USD | -9,230,000USD |
| Capital Expenditures | 0USD | 0USD | -18,000USD | -26,000USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -12,288,000USD | -5,967,000USD | -10,852,000USD | -8,353,999USD | -12,794,000USD | -10,267,000USD | -10,456,000USD | -9,230,000USD |
| Investments | 3,257,000USD | 10,749,000USD | 10,160,000USD | -4,983,000USD | -14,584,000USD | 4,511,000USD | -9,434,000USD | 14,015,000USD |
| Total Cashflows From Investing Activities | 3,257,000USD | 10,749,000USD | 10,160,000USD | -4,983,000USD | -14,584,000USD | 4,511,000USD | -9,434,000USD | 14,015,000USD |
| Total Cash From Financing Activities | 105,000USD | 2,553,000USD | 25,000USD | 0USD | 3,000USD | 44,188,000USD | 7,427,000USD | 2,057,999USD |
| Change In Cash | -8,926,000USD | 7,335,000USD | -649,000USD | -13,311,000USD | -27,375,000USD | 38,432,000USD | -12,463,000USD | 6,843,000USD |
| Begin Period Cash Flow | 17,470,000USD | 10,135,000USD | 10,784,000USD | 24,095,000USD | 51,470,000USD | 13,038,000USD | 25,501,000USD | 18,658,000USD |
| End Period Cash Flow | 8,544,000USD | 17,470,000USD | 10,135,000USD | 10,784,000USD | 24,095,000USD | 51,470,000USD | 13,038,000USD | 25,501,000USD |
| Other Cashflows From Financing Activities | 105,000USD | 2,553,000USD | 25,000USD | — | 3,000USD | 13,000USD | 6,000USD | 6,001USD |
| Issuance Of Capital Stock | — | 0USD | 0USD | — | — | 44,175,000USD | 7,427,000USD | — |
| Other Cashflows From Investing Activities | — | -744,000USD | — | 902,000USD | -902,000USD | — | — | 14,015,000USD |
| Dividends Paid | — | — | — | — | — | — | -6,000USD | -6,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | — | -14,015,000USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | — | — | 2,057,998USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -45,851,000USD | -45,431,000USD | -41,441,000USD | -38,704,000USD | -28,291,000USD | -19,306,672USD | -16,414,000USD | -16,461,000USD |
| Depreciation | 904,000USD | 404,000USD | 398,000USD | 236,000USD | 451,000USD | 466,009USD | 494,000USD | 859,000USD |
| Stock Based Compensation | 5,693,000USD | 4,760,000USD | 4,509,000USD | 4,256,000USD | 3,234,000USD | 1,764,804USD | 885,000USD | 2,175,000USD |
| Other Non Cash Items | -848,000USD | -598,000USD | -921,000USD | 772,000USD | 2,032,000USD | 1,100,415USD | 703,000USD | 764,000USD |
| Change To Account Receivables | 591,000USD | -484,000USD | 483,000USD | -236,000USD | -215,000USD | -116,978,000USD | -35,725,000USD | 19,262,000USD |
| Change In Working Capital | 2,179,000USD | 3,172,000USD | 6,568,000USD | -380,000USD | -1,789,000USD | -654,531USD | 1,092,000USD | 98,000USD |
| Total Cash From Operating Activities | -37,923,000USD | -37,693,000USD | -30,887,000USD | -33,820,000USD | -23,040,000USD | -16,314,962USD | -13,268,000USD | -13,200,000USD |
| Capital Expenditures | -44,000USD | -80,000USD | -582,000USD | -892,000USD | -205,000USD | -211,880USD | -68,000USD | -5,100USD |
| Free Cash Flow | -37,967,000USD | -37,773,000USD | -31,469,000USD | -34,712,000USD | -23,245,000USD | -16,526,842USD | -13,336,000USD | -13,205,100USD |
| Investments | 1,386,000USD | 13,728,000USD | 29,654,000USD | 39,041,000USD | -131,243,000USD | -211,880USD | -67,622USD | 22,842USD |
| Total Cashflows From Investing Activities | 1,342,000USD | 13,728,000USD | 36,195,000USD | 38,149,000USD | -131,448,000USD | -211,880USD | -67,622USD | 23,000USD |
| Total Cash From Financing Activities | 2,581,000USD | 53,780,000USD | 0USD | 75,000USD | 35,450,000USD | 137,312,231USD | 12,078,000USD | 16,403,540USD |
| Issuance Of Capital Stock | 0USD | 53,407,000USD | 0USD | 14,962,000USD | 34,187,000USD | 112,299,949USD | 8,817,772USD | 18,000,027USD |
| Change In Cash | -34,000,000USD | 29,815,000USD | 5,308,000USD | 4,404,000USD | -119,038,000USD | 120,785,389USD | -1,258,000USD | 3,227,000USD |
| Begin Period Cash Flow | 51,470,000USD | 21,655,000USD | 16,347,000USD | 11,943,000USD | 130,981,000USD | 10,195,292USD | 11,453,000USD | 8,226,000USD |
| End Period Cash Flow | 17,470,000USD | 51,470,000USD | 21,655,000USD | 16,347,000USD | 11,943,000USD | 130,980,681USD | 10,195,000USD | 11,453,000USD |
| Other Cashflows From Investing Activities | -744,000USD | — | — | 114,000USD | 114,000USD | 114,000USD | 114,000USD | 23,000USD |
| Other Cashflows From Financing Activities | 2,581,000USD | 373,000USD | 36,195,000USD | 489,000USD | 1,287,000USD | 25,317,282USD | 27,500,000USD | 30,239,429USD |
| Unclassified Investing Cash Flow | — | — | 7,123,000USD | — | — | — | — | — |
| Unclassified Financing Cash Flow | — | — | -36,195,000USD | — | -1,263,000USD | 111,994,949USD | -3,299,281USD | -20,294,629USD |
| Change To Liabilities | — | — | — | 1,306,000USD | 563,000USD | 1,346,064USD | 1,541,704USD | 236,484USD |
| Dividends Paid | — | — | — | -414,000USD | -24,000USD | -24,240,000USD | -24,240,000USD | -24,240,000USD |
| Sale Purchase Of Stock | — | — | — | 75,000USD | 35,450,000USD | 24,240,000USD | 12,117,281USD | 32,074,154USD |
| Cash And Cash Equivalents Changes | — | — | — | 4,404,000USD | -119,038,000USD | 120,785,389USD | -1,257,841USD | 3,227,369USD |
| Net Borrowings | — | — | — | — | 0USD | — | — | -1,375,414USD |
| Unclassified Operating Cash Flow | — | — | — | — | 1,323,000USD | — | — | — |
| Change To Inventory | — | — | — | — | — | -1,159,188,000USD | -1,419,611,000USD | -255,624,245USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.